Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy
Journal of the American Chemical Society · 05.04.2023 · 145 (13) · 7361-7375
DOI: 10.1021/jacs.2c13732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.03.2023. Verfasst von Leo K B Tam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. Hauptthemen laut MEDLINE: Photochemotherapy. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council, University Grants Committee.
Abstract (Originalsprache)
An advanced photodynamic molecular beacon (PMB) was designed and synthesized, in which a distyryl boron dipyrromethene (DSBDP)-based photosensitizer and a Black Hole Quencher 3 moiety were connected via two peptide segments containing the sequences PLGVR and GFLG, respectively, of a cyclic peptide. These two short peptide sequences are well-known substrates of matrix metalloproteinase-2 (MMP-2) and cathepsin B, respectively, both of which are overexpressed in a wide range of cancer cells either extracellularly (for MMP-2) or intracellularly (for cathepsin B). Owing to the efficient Förster resonance energy transfer between the two components, this PMB was fully quenched in the native form. Only upon interaction with both MMP-2 and cathepsin B, either in a buffer solution or in cancer cells, both of the segments were cleaved specifically, and the two components could be completely separated, thereby restoring the photodynamic activities of the DSBDP moiety. This PMB could also be activated in tumors, and it effectively suppressed the tumor growth in A549 tumor-bearing nude mice upon laser irradiation without causing notable side effects. In particular, it did not cause skin photosensitivity, which is a very common side effect of photodynamic therapy (PDT) using conventional "always-on" photosensitizers. The overall results showed that this "double-locked" PMB functioned as a biological AND logic gate that could only be unlocked by the coexistence of two tumor-associated enzymes, which could greatly enhance the tumor specificity in PDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
- Department of Biomedical Sciences and Tung Biomedical Sciences Centre, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China.
- Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.
- School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
ORCID-Profile: Jacky C H Chu, Peter Chi Keung Cheung, Dennis K P Ng, Pui-Chi Lo
Förderung
- Research Grants Council, University Grants Committee
Zitieren
APA
Tam, L. K. B., Chu, J. C. H., He, L., Yang, C., Han, K. C., Cheung, P. C. K., Ng, D. K. P., & Lo, P. C. (2023). Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy. Journal of the American Chemical Society, 145(13), 7361-7375. https://doi.org/10.1021/jacs.2c13732
Vancouver
Tam LKB, Chu JCH, He L, Yang C, Han KC, Cheung PCK, et al. Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy. Journal of the American Chemical Society. 2023;145(13):7361-7375. doi:10.1021/jacs.2c13732
BibTeX
@article{Tam2023,
author = {Tam, Leo K B and Chu, Jacky C H and He, Lin and Yang, Caixia and Han, Kam-Chu and Cheung, Peter Chi Keung and Ng, Dennis K P and Lo, Pui-Chi},
title = {Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {13},
pages = {7361--7375},
doi = {10.1021/jacs.2c13732}
}
EUVIMED